Cargando…
Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review)
Thalassemia is a genetic haematological disorder that arises due to defects in the α and β-globin genes. Worldwide, 0.3-0.4 million children are born with haemoglobinopathies per year. Thalassemic patients, as well as their families, face various serious clinical, socio-economic, and psychosocial ch...
Autores principales: | Amjad, Fareeha, Fatima, Tamseel, Fayyaz, Tuba, Khan, Muhammad Aslam, Qadeer, Muhammad Imran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484974/ https://www.ncbi.nlm.nih.gov/pubmed/32953110 http://dx.doi.org/10.3892/br.2020.1355 |
Ejemplares similares
-
Thalassemia and Nanotheragnostics: Advanced Approaches for Diagnosis and Treatment
por: Tariq, Zahra, et al.
Publicado: (2023) -
Novel Carboxylic Acid-Capped Silver Nanoparticles as Antimicrobial and Colorimetric Sensing Agents
por: Irfan, Muhammad Imran, et al.
Publicado: (2022) -
Genetic Manipulation Strategies for β-Thalassemia: A Review
por: Zakaria, Nur Atikah, et al.
Publicado: (2022) -
Targeting the Second Transferrin Receptor as Emerging Therapeutic Option for β-Thalassemia Major
por: Vinchi, Francesca, et al.
Publicado: (2022) -
Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
por: Zakaria, Nur Atikah, et al.
Publicado: (2021)